Literature DB >> 22271500

Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma.

Yu Imamura1, Masayuki Watanabe, Yohei Nagai, Yoshifumi Baba, Kotaro Hirashima, Ryuichi Karashima, Masaaki Iwatsuki, Naoya Yoshida, Koichi Kinoshita, Junji Kurashige, Ken-Ichi Iyama, Hideo Baba.   

Abstract

BACKGROUND AND OBJECTIVES: D2-40 staining has been reported to be useful for both identifying lymphatic vessel invasion (LVI) and counting lymphatic vessel density (LVD) in various cancers. The aim of this study was to clarify the prognostic significance of D2-40 staining in patients with esophageal squamous cell carcinoma (ESCC).
METHODS: A total of 159 consecutive patients with ESCC who underwent an esophagectomy with lymph node dissection were eligible. LVI was diagnosed by both hematoxylin-eosin (LVI-HE) and D2-40 staining (LVI-D2-40) in the largest central sections of the entire tumors, while both the intratumoral and peritumoral LVD were counted by D2-40 staining. The correlation between the prognosis and clinicopathological factors was investigated.
RESULTS: An univariate analysis revealed that tumor invasion beyond the muscularis propria, lymph node metastasis (LNM), LVI-HE, LVI-D2-40, high intratumoral LVD, and blood vessel invasion correlated with worse patients' prognosis (P < 0.05). A multivariate analysis revealed LNM to be the only independent prognostic factor in all cases (P = 0.0083). On the other hand, when the prognostic factors of 83 patients without LNM were investigated, LVI-D2-40 was revealed to be the only independent prognostic factor (P = 0.048).
CONCLUSIONS: LVI detected by D2-40 staining was an independent prognostic factor in patients with node-negative ESCC.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22271500     DOI: 10.1002/jso.22079

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.

Authors:  Akihiko Wakayama; Wataru Kudaka; Hirofumi Matsumoto; Hajime Aoyama; Takuma Ooyama; Yusuke Taira; Yoshihisa Arakaki; Yuko Shimoji; Tadaharu Nakasone; Kumiko Nishihira; Itomi Kaneshima; Tomoko Tamaki; Naoki Yoshimi; Yoichi Aoki
Journal:  Int J Clin Oncol       Date:  2017-12-23       Impact factor: 3.402

2.  Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.

Authors:  Naoya Yoshida; Yoshifumi Baba; Hironobu Shigaki; Kazuto Harada; Masaaki Iwatsuki; Yasuo Sakamoto; Yuji Miyamoto; Junji Kurashige; Keisuke Kosumi; Ryuma Tokunaga; Masayuki Watanabe; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2016-06-02       Impact factor: 3.402

3.  The prognostic role of angiolymphatic invasion in N0 esophageal carcinoma: a meta-analysis and systematic review.

Authors:  An Wang; Yulong Tan; Yuyan Zhang; Dong Xu; Yuchao Fang; Xiaofeng Chen; Shaohua Wang
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

4.  Peritumoral Lymphatic Vessels Associated with Resistance to Neoadjuvant Chemotherapy and Unfavorable Survival in Esophageal Cancer.

Authors:  Takeo Hara; Tomoki Makino; Makoto Yamasaki; Koji Tanaka; Kotaro Yamashita; Yuya Nogi; Takuro Saito; Tsuyoshi Takahashi; Yukinori Kurokawa; Mitsuaki Tatsumi; Kiyokazu Nakajima; Eiichi Morii; Hidetoshi Eguchi; Yuichiro Doki
Journal:  Ann Surg Oncol       Date:  2020-04-23       Impact factor: 5.344

5.  Detection of D2-40 monoclonal antibody-labeled lymphatic vessel invasion in esophageal squamous cell carcinoma and its clinicopathologic significance.

Authors:  Bing Bai; Wei Ma; Kai Wang; Sita Ha; Jian-Bo Wang; Bing-Xu Tan; Na-Na Wang; Sheng-Si Yang; Yi-Bin Jia; Yu-Feng Cheng
Journal:  Cancer Biol Med       Date:  2013-06       Impact factor: 4.248

Review 6.  Emerging clinical applications of selected biomarkers in melanoma.

Authors:  Michael T Tetzlaff; Carlos A Torres-Cabala; Penvadee Pattanaprichakul; Ronald P Rapini; Victor G Prieto; Jonathan L Curry
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-01-30

7.  Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.

Authors:  Wei Ma; Kai Wang; Shaoqi Yang; Jianbo Wang; Bingxu Tan; Bing Bai; Nana Wang; Yibin Jia; Ming Jia; Yufeng Cheng
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.